Crizotinib/lorlatinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1941卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32418-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[31] Crizotinib/dexamethasoneVarious toxicities: case report
Reactions Weekly, 2015, 1567 (1) : 73 - 73
[32] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2019, 1755 (1) : 102 - 102
[33] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2017, 1675 (1) : 84 - 84
[34] Crizotinib/ginger interactionHepatitis: case report
Reactions Weekly, 2020, 1822 (1) : 106 - 106
[35] Crizotinib/erlotinibRash and diarrhoea: case report
Reactions Weekly, 2016, 1617 (1) : 79 - 79
[36] Crizotinib/dexamethasoneVarious toxicities: case report
Reactions Weekly, 2022, 1913 (1) : 168 - 168
[37] Crizotinib/osimertinibInterstitial pneumonitis: case report
Reactions Weekly, 2021, 1852 (1) : 147 - 147
[38] Brigatinib/crizotinib/lorlatinibVarious toxicities, lack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1948 (1) : 111 - 111
[39] Crizotinib/pralsetinibDiarrhoea and sinus bradycardia: case report
Reactions Weekly, 2023, 1948 (1) : 146 - 146
[40] Crizotinib/Nedaplatin/PemetrexedVarious toxicities: case report
Reactions Weekly, 2025, 2049 (1) : 121 - 121

← 1 2 3 4 5 →